Navigation Links
SENOMYX ANNOUNCES THE EXTENSION OF ITS COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT WITH AJINOMOTO CO., INC.
Date:3/24/2009

a leading company using proprietary taste receptor technologies to discover and develop novel flavor ingredients in the savory, sweet, salt, bitter, and cooling areas. Senomyx has entered into product discovery, development, and commercialization collaborations with seven of the world's foremost food, beverage, and ingredient supply companies: Ajinomoto Co., Inc., Cadbury plc, Campbell Soup Company, The Coca-Cola Company, Firmenich SA, Nestle SA, and Solae. Nestle is currently marketing products that contain one of Senomyx's flavor ingredients. For more information, please visit www.senomyx.com.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding: Senomyx's ability to identify and develop novel flavor ingredients that provide a sufficiently potent effect; the capabilities of Senomyx's flavor ingredients, Senomyx's ability, or Senomyx's collaborators' ability, to commercialize products incorporating Senomyx's flavor ingredients in foods and culinary products; the duration of Senomyx's collaborative, research, development, commercialization and license agreement with Ajinomoto and whether Ajinomoto will elect its option to extend the collaboration for any additional periods and Senomyx's right to receive research fees, milestone payments and royalties under its agreements with its collaborators. Risks that contribute to the uncertain nature of the forward-looking statements include: Senomyx is dependent on its product discovery and development collaborators for all of Senom
'/>"/>

SOURCE Senomyx, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Senomyx Announces Conclusion of Discovery and Development Collaboration With Kraft Foods Global, Inc.
2. SENOMYX ANNOUNCES EXTENSION OF DISCOVERY AND DEVELOPMENT COLLABORATION WITH CADBURY PLC
3. SENOMYX ANNOUNCES INITIATION OF DEVELOPMENT ACTIVITIES FOR NEW SUCROSE ENHANCER
4. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE
5. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE WACHOVIA CONSUMER GROWTH CONFERENCE
6. SENOMYX CO-FOUNDER AND SCIENTIFIC ADVISORY BOARD MEMBER ROGER TSIEN, PH.D., AWARDED NOBEL PRIZE IN CHEMISTRY
7. SENOMYX, INC. THIRD QUARTER 2008 EARNINGS CONFERENCE CALL SCHEDULED FOR NOVEMBER 6, 2008
8. SENOMYX ANNOUNCES RECEIPT OF MILESTONE PAYMENT FROM THE COCA-COLA COMPANY
9. SENOMYX ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS
10. SENOMYX AND FIRMENICH TO COLLABORATE ON COMMERCIALIZATION OF S2383, A NOVEL ENHANCER OF THE HIGH-INTENSITY SWEETENER SUCRALOSE
11. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 11TH ANNUAL NEEDHAM GROWTH STOCK CONFERENCE

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., Dec. 1 Reportlinker.com announce...n its catalogue: ,, Chromium - Global Market ...94/Chromium---Global-Market-Trends.html ,, Wor... by stainless steel, while growth in aerospace and...for growth of chromium metal. Environmental constr...
(Date:12/1/2009)..., Dec. 1 Reportlinker.com announce...n its catalogue: ,, Emerging Clinical Trial Lo...changing healthcare and regulatory environment ,...-Clinical-Trial-Locations---Eastern-Europe-Market-...y-environment.html ,, Over the last decade pha...
(Date:12/1/2009)...GE, Mass., Dec. 1 To address the e...promote its potential, a group of individuals and ... Biology Industry Association (SynBIA) in Cambridg...ation is to provide a forum for individuals and co...dress its opportunities and its challenges, and ad...
(Date:12/1/2009)... Dec. 1 /PRNewswire-Asia/ -- Shanghai ChemPartner,...ing China-based Contract Research,Organization (CR...oitte,Technology Fast 50 China, ranking 3rd on the...n China. The award is a testament to ChemPartner,s...o 2008. , The results of the 2009 Deloitt...
Breaking Biology Technology:Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3
...TON, N.H., May 21 The American Acne & Rosacea...nt of National Acne Awareness Month which will occ...AARS, James Q. Del Rosso, DO, President, stated th...pportunity to educate healthcare providers concern...s for this disease which affects over 17 million A...
...ersal Definition of Myocardial Infarction provided...ties , , TOKYO and INDIANAPOLIS, May 21 Investig...ied the new classification system for the Universa...ts of the study and showed that patients with acut... coronary intervention (PCI) and taking prasugrel,...
...oved for peripheral neuropathic pain in non-diabet...X, Inc. (Nasdaq: NGSX ), a biopharmaceutical com...el pain management therapies, announced today that...eting authorization of Qutenza(TM) 179 mg cutaneou...eripheral neuropathic pain in non-diabetic adults ...
Other Biology Technology:American Acne & Rosacea Society Announces Acne Awareness Month - June 2009 2Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 2Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 3Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 4Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 5Multiple Types of Heart Attacks Reduced by Prasugrel in TRITON-TIMI 38 Trial 6NeurogesX Receives European Commission Approval for Qutenza(TM) 2NeurogesX Receives European Commission Approval for Qutenza(TM) 3NeurogesX Receives European Commission Approval for Qutenza(TM) 4NeurogesX Receives European Commission Approval for Qutenza(TM) 5
(Date:12/2/2009)...urance of a cancer-free status did not prompt peop...raphy (CT) lung-cancer screening program to pick u...tudy published in Cancer Epidemiology, Biomarkers...ion for Cancer Research. The December issue contai...should negate widespread concern in the lung scree...
(Date:12/2/2009)...e University Medical Center researchers have figur...r glioma may be better able to resist radiation th...aling pathway in these cancer stem cells, they wer...on in a laboratory experiment. , The work build...em cells resist the effects of radiation much bett...
(Date:12/2/2009)...reporting the first identification of substances i... changes harmless marine bacteria into killers tha...ACS, Environmental Science & Technology , a semi-...te that bleaching already has destroyed up to 30 p...are searching for ways to slow or stop the damage....
Breaking Biology News(10 mins):Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Discovery makes brain tumor cells more responsive to radiation 2Big Top Cupcake 28TM 29 Brand Awarded With Guinness World Record For Worlds Largest Cupcake 59088 1Big Top Cupcake 28TM 29 Brand Awarded With Guinness World Record For Worlds Largest Cupcake 59088 2National Health Care Reformers Should Pay Attention to Lawsuit Alleging that Nations Largest Insurer Routinely Denies Liver Transplants 59086 1National Health Care Reformers Should Pay Attention to Lawsuit Alleging that Nations Largest Insurer Routinely Denies Liver Transplants 59086 2BayCare Behavioral Health and Homeless Emergency Project Receive Federal Grant to Help Break the Cycle of Homelessness 59084 1BayCare Behavioral Health and Homeless Emergency Project Receive Federal Grant to Help Break the Cycle of Homelessness 59084 2BayCare Behavioral Health and Homeless Emergency Project Receive Federal Grant to Help Break the Cycle of Homelessness 59084 3
...logy have developed a prosthetic vein valve to hel...ition known as chronic venous insufficiency. The c...ople in the United States alone, occurs when valve...ay flow of blood back to the heart. , "Blood fl...ses vein valves to pump blood in one direction bac...
...ORTCNCIAACR Symposium on "Molecular Targets and Ca...Palexpo, Geneva] from Tuesday 21 October-Friday 24...adline for booking accommodation via the official ...organised jointly by the European Organisation for...onal Cancer Institute and the American Association...
...trial of a catheter-based treatment for deep vein ... drugs in combination with clot removal devices to... DVT (the formation of a blood clot in a leg vein)...causes permanent damage to the veins, resulting in...and/or skin ulcers. About 25�� perce...
Other Biology News:Prosthetic vein valve designed to direct blood flow shows promising pre-clinical results 2Prosthetic vein valve designed to direct blood flow shows promising pre-clinical results 3Prosthetic vein valve designed to direct blood flow shows promising pre-clinical results 4Media invitation: 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics 2Pivotal national trial uses newest interventional radiology treatment to bust blood clots in legs 2Pivotal national trial uses newest interventional radiology treatment to bust blood clots in legs 3
Mouse Anti-Hamartin Monoclonal Antibody, Unconjugated, Clone 1B2 from Cell Signaling Technology
Blank Calibration Particles, 3.0-3.4 mu m from BD Biosciences Pharmingen
Rabbit Anti-Human SYT16 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Anti-IL-12 / IL-23 Monoclonal Antibody, Alexa Fluor 647 Conjugated, Clone C17.8 from eBioscience
Biology Products: